radionukliditerapiaan

Radionukliditerapiaan, often translated as radionuclide therapy or radiopharmaceutical therapy, is a type of nuclear medicine treatment that uses radioactive isotopes to target and destroy diseased cells. In this therapy, a radioactive substance, called a radiopharmaceutical, is administered to the patient, typically through injection, orally, or intravenously. This radiopharmaceutical is designed to accumulate in specific tissues or cells, such as cancer cells.

Once the radiopharmaceutical has concentrated in the target area, the radioactive isotopes emit radiation. This radiation, usually in the form of alpha or beta particles, has a short range and delivers a high dose of energy to the surrounding cells. The intent is to damage or destroy the abnormal cells while minimizing damage to healthy tissues. The type of radioisotope used depends on the specific medical condition being treated and the desired therapeutic effect.

Radionukliditerapiaan is commonly used in the treatment of various cancers, including thyroid cancer, prostate cancer, neuroendocrine tumors, and certain types of lymphoma. It can also be employed for non-cancerous conditions like hyperthyroidism. The effectiveness of the therapy is assessed through imaging techniques that can track the distribution of the radiopharmaceutical in the body. While generally considered safe and effective, potential side effects can occur, and patients are closely monitored throughout the treatment process. The radioactive isotopes naturally decay over time, and the radioactivity in the patient's body gradually decreases.